How and why patients made Long Covid.

Callard F, Perego E. · 2021

Read How and why patients made Long Covid. by Callard F, Perego E. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7539940.txt.

Introduction

Callard and Perego trace how patients created the term Long Covid. Many patients had first been told their illness was mild. Their symptoms lasted longer and grew more complex.

Patients found each other first on Twitter. They gathered evidence and shared their accounts widely. The term moved into media within a few months. It then reached clinical and policy channels. Both authors write as patients with the illness. Their account focuses on the UK and USA. They show how patients built shared authority on symptoms. The authors argue patient knowledge must shape research and care.

Catalog record

CREATORCallard F, Perego E.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7539940

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

How and why patients made Long Covid By Felicity Callard, Elisa Perego Published in: Social Science & Medicine (1982) DOI: 10.1016/j.socscimed.2020.113426 ABSTRACT Patients collectively made Long Covid – and cognate term ‘Long-haul Covid’ – in the first months of the pandemic. Patients, many with initially ‘mild’ illness, used various kinds of evidence and advocacy to demonstrate a longer, more complex course of illness than laid out in initial reports from Wuhan. Long Covid has a strong claim to be the first illness created through patients finding one another on Twitter: it moved from patients, through various media, to formal clinical and policy channels in just a few months. This initial mapping of Long Covid – by two patients with this illness – focuses on actors in the UK and USA and demonstrates how patients marshalled epistemic authority. Patient knowledge needs to be incorporated into how COVID-19 is conceptualised, researched, and treated. CREDIT AUTHOR STATEMENT Felicity Callard, Elisa Perego: Conceptualization, Investigation, Writing - original draft preparation, Writing – Reviewing and editing OUT OF COLLECTIVE SUFFERING Long Covid describes a longer, more complex course of illness than that emerging from initial, formal reports from Wuhan (The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020; World Health Organization, 2020a). We document how and why patients made Long Covid – and cognate term long-haulers – and why this matters for patient activism and pandemic policy-making. While most patients initially had ‘mild’ COVID-19 and were not hospitalized, many experienced life-threatening symptoms as well as other traumatic events, often without healthcare support. Thousands of patients collectively made visible heterogeneous and complexly unfolding symptoms: most were not commonly acknowledged within many healthcare and policy channels in early pandemic months. How scientists engage with knowledge about new diseases affects how meaning about a disease accrues, how terminology solidifies, and which evidence is prioritized. In a global health crisis, we need contributions made by those with wide ranges of expertise – including, crucially, patients. There is a long history of those outside formal clinical channels refining or contesting knowledge produced within biomedicine. Mental health survivors have challenged diagnostic categories and developed different ways to conceptualize distress and recovery (Sweeney et al 2009); HIV/AIDS activists have changed how biomedical scientific research is conducted and how drugs are accessed (Robins, 2004); those with long-term/chronic conditions have created patient knowledge and ways of living (Pols, 2013; Kingod, 2018); political organizations have made clear the biopolitical stakes of health and illness (Nelson, 2011). These patient and lay contributions have often been ignored or underacknowledged by conventional actors, which has intensified patient suffering and societal inequalities. We need to learn from these episodes and ensure that patient contributions to the coronavirus pandemic are fully acknowledged and incorporated into policy making . The speed of publication of COVID-19 research means epistemic authority rapidly consolidates around particular actors. Crucial leads might be lost as background noise – particularly when made by patients, whose expertise is less frequently validated. Long Covid now appears in peer-reviewed publications (e.g. Altmann and Boyton, 2020; Greenhalgh et al., 2020). Many now writing about it are not aware of whence and why it arose. By starting to map Long Covid and related iterations (including ‘long-haulers’) which have started to emerge in the English language, we aim to ensure their patient origins are evidenced within the peer-reviewed literature, as well as emphasize why conventional health actors ought to include these contributions within formal scientific practices. Long Covid as a patient-made illness carries the potential to change how the pandemic unfolds. It has already challenged dominant assumptions about morbidity and disease severity: as science writer Ed Yong has argued, Covid ‘[l]ong-haulers … are redefining COVID-19’ (Yong, 2020b). There are strong reasons to argue that Long Covid is the first illness to be made through patients finding one another on Twitter and other social media. Both of us have Long Covid and have contributed to making it. Here, we focus on contributions from the UK and USA, while emphasizing the need for research on patient contributions from other countries – including China, South Korea, and Spain, which were affected earlier in the pandemic. EXPLODING ‘MILD’ COVID The February WHO-China Report stated ‘the median time from onset to clinical recovery for mild cases is approximately 2 weeks and is 3–6 weeks for patients with severe or critical disease’ (World Health Organization, 2020a). Early reports focused on severe pneumonia; the ‘mild’ was a capacious category including some with pneumonia. Many citizens were told most patients would experience mild illness and rapid recovery. The UK's Chief Medical Officer Chris Whitty stated, in May, ‘the great majority, probably 80%, will have a mild or moderate disease, might be bad enough for them to go to bed for a few days, not bad enough for them to have to go to the doctor’ (Refer video at 46 minutes in 10 Downing Street, 2020). Emollient descriptions of mild illness did not fit with people's often overwhelming experiences. In March, patients started sharing experiences on social media, drawing attention to possible Covid-related sequelae (e.g. Pope, 2020). In April, newspapers started publishing first-person accounts documenting how challenging recovery from COVID-19 could be (e.g. Lowenstein, 2020). Articles often drew on resources developed within patient-founded groups – e.g. Body Politic COVID-19 Support Group (https://www.wearebodypolitic.com/covid19, founded by Fiona Lowenstein and Sabrina Bleich), and Facebook groups (e.g. https://www.facebook.com/groups/longcovid, founded by Claire Hastie). On 5 May, the British Medical Journal (BMJ) published Paul Garner's account of suffering seven weeks through a ‘roller coaster of ill health, extreme emotions and utter exhaustion’ (Garner, 2020). Garner, an infectious diseases professor, also appeared in a feature (Harding, 2020b), which, by 10 August, had been read over 1 million times (Harding, 2020a). Garner's account travelled internationally, gathering a wider patient community around what he termed the Covid ‘long tail’. Garner reported patients took his account to medical appointments to provide evidence of the realness of their symptoms (Colbert et al. n. d.). Patient-made evidence in the form of one case study was important when no peer-reviewed articles had yet documented long-lasting symptoms. Non-hospitalized patients were at that point literally beyond the gaze of biomedical research. Patients also challenged ‘mild’: Felicity Callard, then seven weeks into Covid, anatomized the ‘mild’, emphasizing how little was known about whether mild illness was actually mild (Callard, 2020). On 11 May, an all-patient team published the first survey of prolonged symptoms reporting over 50 (including cognitive impairment/fatigue, chills/sweats, appetite loss), many of them cyclical (Assaf et al., 2020); the chance of full recovery by day 50 after onset was less than 20% (see also Lambert, 2020). Other patient-led initiatives included Gez Medinger's videos (https://www.youtube.com/channel/UCln_SCEd4JiGkHIUZd1VlXw), and Kate Porter's ‘COVID-19 Recovery Awareness’ (https://www.c19recoveryawareness.com). LONG-HAULERS In early June, Yong published ‘COVID-19 can last for several months’ (Yong, 2020a). Yong's reputation and the article's calibre ensured wide circulation. (By 19 August, 1 million visitors had read the online version [personal communication, Yong, August 19, 2020]). Yong's article featured nine people, described support groups ‘hosting thousands’, and noted some called themselves ‘long-haulers’. ‘Long-haulers’ came from Amy Watson, patient convener of ‘Long haul Covid fighters’, who derived it from a trucker hat she was wearing when getting a test (Porter, 2020). ‘Long-haulers’ soon

Read the complete text